S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Clinical trial NCT03723928 · RECRUITING

Trial details

NCT number: NCT03723928
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Estrogen Receptor Positive HER2/Neu Negative Progesterone Receptor Positive Prognostic Stage IV Breast Cancer AJCC v8 Elevated CA15-3 or CEA or CA27-29

Start date: 2018-09-17
Primary completion: 2030-12-01
Enrollment: 739

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.